NCT04270916View on ClinicalTrials.gov

Prevalence and Impact on QoL From Ototoxicity in Cancer Survivors

SuspendedOBSERVATIONAL
Enrollment

46

Participants

Timeline

Start Date

February 3, 2020

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2020

Conditions
Hearing Loss, SensorineuralTinnitus, SubjectiveCancerChemotherapeutic Toxicity
Interventions
DIAGNOSTIC_TEST

High frequency pure tone audiometry

Hearing test carried out routinely, non invasive

Trial Locations (1)

NG5 1PB

Nottingham University Hospitals NHS trust, Nottingham

Sponsors
All Listed Sponsors
collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

collaborator

International Stem Cell Forum

OTHER

lead

University of Nottingham

OTHER